XPhyto Therapeutics Corp. announced the execution of Covid-ID Lab sales contracts with both digitallifecare Corona Testzentren, powered by digitallifecare GmbH, Germany and a group of pharmacies in Bamberg, Germany. Digitallife operates five coronavirus test centers south of Stuttgart, Germany, servicing a local community of approximately 75,000.

Personnel training and equipment installation were completed last week and the first order of test kits has been delivered. In addition to testing for the general public, digitallife will also service corporate clients in the region with COVID-ID Lab PCR testing. The Company also commenced selling to pharmacies in Bamberg, Germany servicing a local community of approximately 78,000.